The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
T

Cardiotoxicities and PLD in mBC: Is It More Efficient Than Conventional Doxorubicin? Should We Use It in Trastuzumab Combo for HER2+ Disease?

By The Asian Oncology Society 1st Virtual International Conference FEATURING Tom Wei-Wu Chen
By The Asian Oncology Society 1st Virtual International Conference FEATURING Tom Wei-Wu Chen
0 views
February 18, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Breast
24:13
The Asian Oncology Society 1st Virtual International Conference

Efficiency of ICI With Chemo for BC: Cancer Immune Cycle, Tumor Muta…

Feat. S. Glueck
10:54
The Asian Oncology Society 1st Virtual International Conference

Chemo Strategies for mBC: Should We Use Longer 1L Duration to Improv…

Feat. C. Liu
13:23
The Asian Oncology Society 1st Virtual International Conference

Cardiotoxicities and PLD in mBC: Is It More Efficient Than Conventio…

Feat. T. Wei-Wu Chen
32:25
The Asian Oncology Society 1st Virtual International Conference

Residual Disease After Neoadjuvant Therapy - Updates on KATHERINE Tr…

Feat. E. Perez